Our technology 

The premier full-spectrum product platform

Growing body of microbiota transfer studies report transformational outcomes for patients 

Intestinal microbiota transfer (IMT)

The transfer of microbiome communities from a healthy person into the intestinal tract of another person suffering from a microbiome mediated disease

IMT is the most powerful means to enhance the microbiome

The number of IMT clinical trials has increased dramatically since 2010

 

Traditional intestinal microbiome transplant products

  • Liquid suspensions, brown colour with odour

  • Stored frozen at -80 degrees celsius 

  • Variable donor dependent composition

  • Variable safety screening under non-GMP controls

  • Non scalable processes

  • Administered through invasive procedures

Image credit: F Gandolfo MD

EnteroBiotix has developed the premier approach to intestinal microbiota transfer

We’ve established full control over the supply chain

 

The premier platform

Premier full-spectrum medicines

EnteroBiotix full spectrum medicines – product features
 
 

CASE STUDY

IMT in liver disease

Increasing diversity through intestinal microbiota transfer improves liver disease and hepatic encephalopathy

IMT Evidence
IMT Mechanisms